Johnson & Johnson (JNJ)
154.64
+0.36
(+0.23%)
USD |
NYSE |
May 17, 16:00
153.94
-0.70
(-0.45%)
Pre-Market: 07:00
Johnson & Johnson Cash from Operations (Annual): 22.79B for Dec. 31, 2023
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 22.79B |
| December 31, 2022 | 21.19B |
| December 31, 2021 | 23.41B |
| December 31, 2020 | 23.54B |
| December 31, 2019 | 23.42B |
| December 31, 2018 | 22.20B |
| December 31, 2017 | 21.06B |
| December 31, 2016 | 18.77B |
| December 31, 2015 | 19.57B |
| December 31, 2014 | 18.71B |
| December 31, 2013 | 17.41B |
| December 31, 2012 | 15.40B |
| December 31, 2011 | 14.30B |
| December 31, 2010 | 16.38B |
| December 31, 2009 | 16.57B |
| December 31, 2008 | 14.97B |
| December 31, 2007 | 15.02B |
| December 31, 2006 | 14.25B |
| Date | Value |
|---|---|
| December 31, 2005 | 11.80B |
| December 31, 2004 | 11.09B |
| December 31, 2003 | 10.60B |
| December 31, 2002 | 8.176B |
| December 31, 2001 | 8.864B |
| December 31, 2000 | 6.903B |
| December 31, 1999 | 5.92B |
| December 31, 1998 | 4.991B |
| December 31, 1997 | 4.343B |
| December 31, 1996 | 3.891B |
| December 31, 1995 | 3.382B |
| December 31, 1994 | 2.975B |
| December 31, 1993 | 2.168B |
| December 31, 1992 | 2.141B |
| December 31, 1991 | 1.675B |
| December 31, 1990 | 1.657B |
| December 31, 1989 | 1.25B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Annual) Range, Past 5 Years
21.19B
Minimum
2022
23.54B
Maximum
2020
22.87B
Average
23.41B
Median
2021
Cash from Operations (Annual) Benchmarks
| Amgen Inc | 8.471B |
| Eli Lilly and Co | 4.240B |
| Merck & Co Inc | 13.01B |
| Pfizer Inc | 8.70B |
| Shockwave Medical Inc | 196.05M |